Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 8-K12B Notification of registration of securities
- 2.2 Letter Agreement
- 3.1 Memorandum and Articles of Association of JAZZ Pharmaceuticals PLC
- 10.1 Form of Indemnification Agreement
- 10.2 Registration Rights Agreement
- 10.3 Escrow Agreemenrt
- 14.1 Code of Conduct of JAZZ Pharmaceuticals PLC
- 16.1 Letter of Ernst & Young LLP
- 99.1 Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Material Modifications to Rights of Security Holders; Changes in Registrant's Certifying Accountant; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics; Other Events; Financial Statements and Exhibits
Filing view
External links
Exhibit 16.1
January 18, 2012
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Ladies and Gentlemen:
We have read Item 4.01 of Form 8-K dated January 18, 2012, of Jazz Pharmaceuticals plc (formerly known as Jazz Pharmaceuticals, Inc.) and are in agreement with the statements contained in the third paragraph on page 4 therein. We have no basis to agree or disagree with other statements of the registrant contained therein.
/s/ Ernst & Young LLP